Viz.ai

by Viz.ai  · Based in United States → — The proven AI-powered care coordination platform.
Emergency Medicine Neurology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Viz.ai is an enterprise-grade, AI-powered care coordination platform designed to accelerate diagnostic and treatment decisions across clinical networks. The platform utilizes advanced algorithms to analyze medical imaging and diagnostic data, including CT scans, EKGs, and echocardiograms, automatically detecting suspected pathologies in real time.

The platform is built for multidisciplinary clinical teams, including specialists in neurology, cardiology, vascular medicine, pulmonology, oncology, trauma, and radiology, operating in emergency, acute, and outpatient care settings. By integrating directly into existing hospital imaging and communication systems, Viz.ai automatically flags critical findings and sends secure, mobile alerts to the relevant specialists.

Key capabilities and clinical suites include:

  • Viz Neuro: Detects large vessel occlusions (LVO), cerebral aneurysms, and hemorrhages to streamline acute stroke workflows.
  • Viz Cardio & Vascular: Identifies conditions such as hypertrophic cardiomyopathy, aortic disease, and pulmonary embolism.
  • Viz Pulmonary & Trauma: Assists in the rapid detection of pulmonary conditions and coordinates care for acute trauma cases.
  • Viz Assist: A mobile and desktop workflow assistant that enables secure communication, image viewing, and coordinated patient triage.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered disease detection and triage across multiple therapeutic areas
  • Real-time insights and automated assessments from medical imaging data (CT, EKG, echocardiograms)
  • Accelerated diagnosis and treatment decisions
  • Streamlined clinical workflows and care coordination (Viz.ai One)
  • HIPAA-compliant communication platform for multidisciplinary teams
  • High-fidelity imaging access on mobile and web devices
  • Viz Agent Studio for building and scaling custom AI care pathways
  • Viz Assist for workflow support, including generative AI for clinical summaries and documentation
  • Integration with existing PACS, EHR, and cloud environments
  • Clinically validated with measurable impacts on patient and economic outcomes

Use Cases

  • Accelerating detection and treatment of neurovascular diseases (e.g., LVO stroke, cerebral aneurysm, ICH)
  • Transforming patient outcomes in cardiovascular diseases (e.g., HCM, ACS, cardiac amyloidosis)
  • Improving patient management in vascular medicine (e.g., aortic disease, pulmonary embolism)
  • Streamlining communications and improving patient response in trauma care
  • Optimizing radiology workflows for faster diagnosis and treatment recommendations
  • Early detection and guideline-directed interventions in oncology

What Physicians Need to Know

Evidence Base
Viz.ai is supported by over 100 published, peer-reviewed abstracts and manuscripts, demonstrating real-world clinical evidence. Its AI-enhanced clinical workflows for neuroimaging are recommended as foundational requirements for stroke centers by the 2023 AHA scientific statement. The platform's solutions are designed to enhance adherence to clinical guidelines across various specialties, including neurology, cardiology, vascular, and trauma.
Clinical Validation Studies
Numerous studies validate Viz.ai's impact, including a 2024 International Stroke Conference presentation of six studies showing positive outcomes in neurology, such as an 11-minute reduction in door-to-groin time with Viz LVO implementation. Viz Aneurysm demonstrated 96.6% sensitivity and 98.1% specificity, while Viz AAA showed over 85% sensitivity and 98.3% specificity. A multicenter pilot for hypertrophic cardiomyopathy (HCM) successfully integrated AI-enhanced ECG to identify undiagnosed patients. Viz PE has shown a 98% decrease in time to assessment and a 74% reduction in in-hospital mortality for pulmonary embolism. An independent FDA-funded study highlighted Viz.ai's better performance, including higher detection rates and faster care team mobilization, with 11% higher specificity and ~30% higher positive predictive value than a competitor.
Alert Fatigue Management
Viz.ai allows providers to disable or limit alerts at their discretion to help manage alert fatigue. The system is designed to present essential information clearly and concisely, aiming to avoid overwhelming users. Algorithms are developed to reduce false positives, which are a known contributor to alarm desensitization.
Override Rate Data
Specific override rate data is not publicly detailed. However, Viz.ai functions as a 'notification-only, parallel workflow tool,' meaning the final diagnostic and treatment decisions remain with the clinician, with the AI serving to assist and inform.
Differential Diagnosis Support
Viz.ai primarily acts as a detection and triage tool for specific suspected conditions (e.g., LVO stroke, aneurysms, ICH, PE, HCM, cardiac amyloidosis) based on imaging analysis. Its new Viz Assist platform integrates EHR data and ambient listening to create generative AI summaries, providing a more comprehensive patient picture that can indirectly support differential considerations by surfacing relevant insights.
Guideline Update Frequency
While a specific update frequency for guidelines is not stated, Viz.ai emphasizes continuous clinical research and product development, with its AI models regularly updated and validated. The platform is designed to enhance adherence to current clinical guidelines.
Clinical Workflow Integration
Viz.ai One integrates seamlessly with existing PACS, EHR, and cloud environments, providing real-time clinical intelligence from over 50 AI models. It delivers alerts faster than conventional methods, embeds AI insights directly into radiology workflows, and prioritizes worklists for acute findings. The platform facilitates multidisciplinary care team coordination across mobile and desktop devices.
Decision Audit Trail
Viz.ai maintains a comprehensive security and privacy program, including SOC 2 Type II and HIPAA compliance, with regular independent audits. This robust compliance framework implies the presence of detailed logging and auditing capabilities for data access and system actions, supporting accountability and traceability of clinical insights and communications within the platform.
Physician Tip

Leverage Viz.ai for rapid detection and triage of time-sensitive conditions like stroke, PE, and aneurysms to significantly reduce time to treatment. Utilize the integrated communication tools to quickly coordinate care with multidisciplinary teams across different locations. Customize alert settings to manage potential alert fatigue, focusing on critical notifications relevant to your workflow. Access high-fidelity images and AI insights on mobile devices for informed decision-making at the point of care. Integrate Viz.ai with existing PACS and EHR systems to streamline workflows and gain comprehensive patient context. For conditions like HCM and cardiac amyloidosis, use Viz.ai to aid in earlier identification and ensure patients are not lost to follow-up.

Viz.ai One is designed for broad interoperability, integrating seamlessly with existing Picture Archiving and Communication Systems (PACS), Electronic Health Records (EHR) systems, and cloud environments, including Microsoft Cloud for Healthcare. It also integrates with radiology worklist systems and communication platforms like Pulsara. The platform supports real-time data exchange and triggers workflows in connected systems, including Salesforce for life sciences and health systems, to facilitate coordinated action and patient activation. This extensive integration capability allows for a unified experience across the care continuum, providing relevant contextual data and AI insights directly within clinicians' existing workflows.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing
  • Subscription-based model; tiered pricing likely based on hospital type (e.g., primary vs
  • comprehensive stroke center)
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Viz.ai's platform features more than 50 FDA-cleared AI algorithms. Specific FDA clearances include Viz LVO (Large Vessel Occlusion), Viz ICH (Intracerebral Hemorrhage), Viz CTP (CT Perfusion), Viz ANEURYSM, Viz SDH (Subdural Hemorrhage), and Viz HCM (Hypertrophic Cardiomyopathy), among others.

Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

What the Web Says

Viz.ai is an AI-powered care coordination platform widely adopted in nearly 2,000 hospitals, primarily for its imaging triage capabilities in time-sensitive conditions like stroke and pulmonary embolism. Physicians generally view the platform positively, noting its ability to significantly reduce time-to-treatment and improve workflow efficiency. While the technology is praised for its accuracy and impact on patient care, some users have noted areas for improvement in user management and vendor support.

Overall: Positive

Strengths

  • Significantly reduces time-to-treatment for critical conditions like stroke, PE, and aortic dissection.
  • Improves care coordination and communication among multidisciplinary care teams.
  • AI algorithms are highly accurate (around 95%) in detecting critical findings.
  • Integrates well with existing hospital infrastructure like PACS and EHRs.
  • Helps prioritize cases and allows for quicker decision-making by physicians.
  • Non-technical users found the onboarding process relatively smooth.

Limitations

  • Enterprise-only pricing makes it inaccessible to individual physicians.
  • Occasional flagging of clinically insignificant findings (e.g., subsegmental PEs).
  • Some users have experienced issues with SSO and user management.
  • Vendor support has been responsive but not always timely.
  • AI sometimes flags cases without displaying the specific area of concern, and study quality assurance can be suspect.
  • Lack of statistically significant differences in patient clinical outcomes despite workflow improvements.

Based on reviews from: Clinical AI Report, CREAITIQUE, Comparably, FeaturedCustomers, G2, The Silicon Review, Viz.ai (Official Website/Blog), App Store, PMC (PubMed Central), Reddit, Forbes, Outofpocket.health, UC Davis Health

Last updated: 2026-07-22

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Viz.ai

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Business Wire
Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration
Viz.ai announced a collaboration with Cortechs.ai to integrate their neuroimaging solutions into the Viz.ai platform, marking Viz.ai's expansion into neurodegenerative diseases like multiple sclerosis.
2026-07
Viz.ai
Viz.ai Launches Viz Pulmonary Suite, the First Comprehensive AI-Powered Solution Dedicated to Pulmonary Care Delivery
Viz.ai launched its Viz Pulmonary Suite, an AI-powered solution designed to streamline care delivery for acute and chronic pulmonary conditions, aiming to improve early detection and patient management.
2026-05
Viz.ai
Viz.ai Achieves ISO/IEC 42001 Certification, Setting the Standard for Agentic AI in Healthcare
Viz.ai announced it has achieved ISO/IEC 42001 certification, validating its enterprise-grade AI governance framework for safe and scalable agentic clinical workflows in healthcare.
2026-05
Business Wire
Viz.ai Announces Strategic Collaboration to Expand Access to AI-Powered Subdural Hemorrhage Care
Viz.ai partnered with Johnson & Johnson to expand access to its Subdural Hemorrhage software solution, which uses AI for automated detection, labeling, and quantification of subdural collections.
2026-04
Viz.ai
Viz.ai Study Demonstrates 44% Reduction in Interfacility Stroke Transfer Times
A study presented at the International Stroke Conference 2026 showed that the Viz.ai platform led to a 44% reduction in door-in-door-out times for large vessel occlusion stroke patients in regional care settings.
2026-03
Viz.ai
Three New Studies Show Viz.ai's Cardio Suite Speeds Detection of Cardiac Disease and Improves Patient Follow-Up
Viz.ai announced three abstracts featuring Viz HCM, its AI-powered ECG analysis and care coordination solution for hypertrophic cardiomyopathy, were accepted for presentation at ACC.26.
2026-03
Viz.ai
Viz.ai and Salesforce Launch Real-Time Clinical Intelligence for Agentforce Life Sciences
Viz.ai launched a new real-time clinical intelligence service for Salesforce's Agentforce Life Sciences, powering agentic solutions with Viz.ai's real-time data and clinical intelligence.
2026-01
Viz.ai
New Study Highlights Positive Impact of Viz.ai on Enhancing Post-Stroke Patient Care
A clinical study published in The Neurohospitalist demonstrated that the Viz Connect care pathway improved cardiac monitoring utilization, care efficiency, and patient satisfaction in post-stroke care.
2025-02

Videos

Product demos, reviews, and walkthroughs for Viz.ai.

View all on YouTube

Frequently Asked Questions

Viz.ai integrates seamlessly with existing Electronic Health Record (EHR) and Picture Archiving and Communication Systems (PACS) to streamline clinical workflows. It provides real-time, AI-powered analysis of medical images and facilitates HIPAA-compliant communication among multidisciplinary care teams on mobile and desktop devices, ensuring rapid information sharing and coordinated action.
Viz.ai offers AI algorithms for detecting and managing various acute conditions, including large vessel occlusion (LVO) strokes, intracerebral hemorrhage (ICH), subdural hemorrhage (SDH), and pulmonary embolism (PE). For LVO detection, studies have shown high accuracy, with reported sensitivities around 81-94% and specificities around 92-96%.
Yes, Viz.ai has received multiple FDA 510(k) clearances for its various AI algorithms, including those for stroke triage, automated CT perfusion, and quantification of subdural and intracerebral hemorrhages. The platform is also designed to comply with federal patient privacy laws, such as HIPAA, ensuring secure communication and data handling.
The main benefits include significantly reducing time to diagnosis and treatment, improving care coordination, and enabling faster, more informed clinical decisions by prioritizing critical cases. However, some studies have noted that while workflow metrics improve, statistically significant differences in certain clinical outcomes like mortality rates are not always observed, and there is a potential for 'alert fatigue' among users.
Viz.ai is one of the leading AI-powered platforms in stroke care, often compared with alternatives like RapidAI and Brainomix. While all aim to expedite stroke diagnosis and management, Viz.ai emphasizes its comprehensive platform with over 50 FDA-cleared algorithms and integrated care coordination across multiple disease states.
Viz.ai typically operates on a subscription-based model, with costs varying depending on the hospital's size and the number of disease modules implemented. For certain technologies, Medicare has granted reimbursement through the New Technology Add-on Payment (NTAP) program, which provides supplemental payments to hospitals for eligible cases.
Viz.ai has consistently demonstrated significant improvements in workflow metrics, such as reducing door-to-treatment times and enhancing care coordination, which are crucial for time-sensitive conditions like stroke. While direct statistically significant improvements in certain long-term clinical outcomes like mortality are still under further investigation, faster treatment times are generally associated with better patient prognoses.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

More from Viz.ai

ContaCT
Viz.AI
Neurology AI
Viz.ai is a pioneering AI-powered care coordination platform that accelerates disease detection and streamlines clinical workflows. With multiple FDA clearances, including the initial Viz.AI Contact application for stroke, it helps ensure patients receive timely treatment across over 1,700 hospitals globally.
Viz AAA
Viz.ai
Cardiology AI
Viz AAA is the first FDA-cleared AI-powered solution by Viz.ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination.
Viz ANEURYSM
Viz.ai
Neurology AI
Viz ANEURYSM is an FDA-cleared AI-powered solution by Viz.ai that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management.
Viz CTP
Viz.ai
Clinical Decision Support & Reference
Viz.ai is a pioneer in AI-powered disease detection and intelligent care coordination, leveraging over 50 FDA-cleared algorithms to analyze medical imaging and streamline clinical workflows for faster diagnosis and treatment.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-22 | First Added: 2026-04-22

Investors who backed Viz.ai

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.